SCHEMBL10749778

SCHEMBL10749778

S=c1c2cc(Cl)c(Cl)cc2[se]n1-c1ncccn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10501557 0.82 CD274 (0.34) —
SCHEMBL10747300 0.81 NR4A2 (0.33) —
SCHEMBL10748041 0.81 METAP2 (0.38) —
SCHEMBL10501665 0.77 METAP2 (0.42) —
SCHEMBL10501845 0.76 KDM4E (0.31) —
SCHEMBL10745189 0.75 ALDH1A1 (0.34) —
SCHEMBL10747582 0.75 METAP2 (0.40) —
SCHEMBL11020733 0.72 METAP2 (0.38) —
SCHEMBL10747318 0.72 KDM4E (0.32) —
SCHEMBL10748075 0.72 MAPT (0.40) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4711961-A Benzisoselenazolethiones and process for the treatment of various diseases in humans A. NATTERMANN & CIE GMBH (DE) 1987-12-08 — — US disclosed
EP-0154851-A1 Benzisoselenazolethiones,process for their preparation and pharmaceutical products containing these compounds A. Nattermann & Cie. GmbH (DE) 1985-09-18 — — EP disclosed
Send feedback